Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis

More clinical evidence is needed regarding the relative priority of treatments for brain metastases (BMs) from EGFR/ALK-negative/unselected non-small cell lung cancer (NSCLC). PubMed, EMBASE, Web of Science, Cochrane Library, and ClinicalTrials.gov databases were searched. Overall survival (OS), cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chengkai, Zhou, Wenjianlong, Zhang, Dainan, Ma, Shunchang, Wang, Xi, Jia, Wang, Guan, Xiudong, Qian, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938645/
https://www.ncbi.nlm.nih.gov/pubmed/36820064
http://dx.doi.org/10.1515/med-2022-0574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938645/
https://www.ncbi.nlm.nih.gov/pubmed/36820064
http://dx.doi.org/10.1515/med-2022-0574

Ejemplares similares